Citigroup’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $667K | Buy |
116,820
+99,813
| +587% | +$453K | ﹤0.01% | 3742 |
|
|
2026
Q1 | $76.5K | Sell |
17,007
-18,923
| -53% | -$98.6K | ﹤0.01% | 4374 |
|
|
2025
Q4 | $221K | Sell |
35,930
-43,565
| -55% | -$316K | ﹤0.01% | 3954 |
|
|
2025
Q3 | $575K | Sell |
79,495
-44,258
| -36% | -$263K | ﹤0.01% | 3509 |
|
|
2025
Q2 | $657K | Sell |
123,753
-119,836
| -49% | -$708K | ﹤0.01% | 3453 |
|
|
2025
Q1 | $2.16M | Buy |
243,589
+51,351
| +27% | +$617K | ﹤0.01% | 2630 |
|
|
2024
Q4 | $2.64M | Buy |
192,238
+74,056
| +63% | +$1.37M | ﹤0.01% | 2577 |
|
|
2024
Q3 | $3.24M | Buy |
118,182
+35,204
| +42% | +$953K | ﹤0.01% | 2235 |
|
|
2024
Q2 | $2.03M | Sell |
82,978
-184,128
| -69% | -$4.04M | ﹤0.01% | 2341 |
|
|
2024
Q1 | $5.69M | Buy |
267,106
+147,679
| +124% | +$3.17M | ﹤0.01% | 1616 |
|
|
2023
Q4 | $2.29M | Sell |
119,427
-2,353
| -2% | -$40.7K | ﹤0.01% | 2130 |
|
|
2023
Q3 | $1.95M | Buy |
121,780
+5,799
| +5% | +$110K | ﹤0.01% | 1998 |
|
|
2023
Q2 | $2.69M | Sell |
115,981
-59,092
| -34% | -$1.29M | ﹤0.01% | 1947 |
|
|
2023
Q1 | $4.07M | Buy |
175,073
+32,890
| +23% | +$668K | ﹤0.01% | 1609 |
|
|
2022
Q4 | $2.06M | Sell |
142,183
-55,320
| -28% | -$1.03M | ﹤0.01% | 2014 |
|
|
2022
Q3 | $3.77M | Buy |
197,503
+48,282
| +32% | +$1.11M | ﹤0.01% | 1707 |
|
|
2022
Q2 | $2.71M | Buy |
149,221
+42,537
| +40% | +$883K | ﹤0.01% | 1898 |
|
|
2022
Q1 | $2.69M | Sell |
106,684
-107,972
| -50% | -$2.76M | ﹤0.01% | 2111 |
|
|
2021
Q4 | $5.92M | Buy |
214,656
+81,995
| +62% | +$2.38M | ﹤0.01% | 1701 |
|
|
2021
Q3 | $4.28M | Sell |
132,661
-70,370
| -35% | -$2.34M | ﹤0.01% | 1931 |
|
|
2021
Q2 | $6.21M | Buy |
203,031
+61,974
| +44% | +$1.79M | ﹤0.01% | 1736 |
|
|
2021
Q1 | $4.3M | Buy |
141,057
+93,915
| +199% | +$2.67M | ﹤0.01% | 1886 |
|
|
2020
Q4 | $932K | Buy |
47,142
+16,976
| +56% | +$274K | ﹤0.01% | 3605 |
|
|
2020
Q3 | $393K | Sell |
30,166
-120,551
| -80% | -$1.53M | ﹤0.01% | 4060 |
|
|
2020
Q2 | $1.71M | Buy |
150,717
+23,206
| +18% | +$330K | ﹤0.01% | 2994 |
|
|
2020
Q1 | $1.82M | Buy |
127,511
+71,221
| +127% | +$1.5M | ﹤0.01% | 2565 |
|
|
2019
Q4 | $1.53M | Sell |
56,290
-73,228
| -57% | -$2.01M | ﹤0.01% | 3286 |
|
|
2019
Q3 | $3.71M | Buy |
129,518
+49,545
| +62% | +$1.44M | ﹤0.01% | 2215 |
|
|
2019
Q2 | $2.22M | Sell |
79,973
-2,381
| -3% | -$67.2K | ﹤0.01% | 2742 |
|
|
2019
Q1 | $2.73M | Sell |
82,354
-143,995
| -64% | -$4.38M | ﹤0.01% | 2344 |
|
|
2018
Q4 | $6.58M | Buy |
226,349
+211,259
| +1,400% | +$7.6M | 0.01% | 1593 |
|
|
2018
Q3 | $694K | Buy |
15,090
+8,170
| +118% | +$363K | ﹤0.01% | 3883 |
|
|
2018
Q2 | $258K | Buy |
6,920
+504
| +8% | +$17K | ﹤0.01% | 4795 |
|
|
2018
Q1 | $189K | Sell |
6,416
-112,463
| -95% | -$3.81M | ﹤0.01% | 5028 |
|
|
2017
Q4 | $4.08M | Buy |
118,879
+19,748
| +20% | +$666K | ﹤0.01% | 2026 |
|
|
2017
Q3 | $3.59M | Sell |
99,131
-63,187
| -39% | -$1.8M | ﹤0.01% | 2062 |
|
|
2017
Q2 | $4.2M | Buy |
162,318
+27,107
| +20% | +$575K | ﹤0.01% | 1848 |
|
|
2017
Q1 | $2.6M | Sell |
135,211
-250,341
| -65% | -$4.44M | ﹤0.01% | 2216 |
|
|
2016
Q4 | $6.43M | Buy |
385,552
+363,402
| +1,641% | +$6.57M | 0.01% | 1569 |
|
|
2016
Q3 | $456K | Buy |
22,150
+5,645
| +34% | +$143K | ﹤0.01% | 3975 |
|
|
2016
Q2 | $505K | Sell |
16,505
-49,200
| -75% | -$1.71M | ﹤0.01% | 3651 |
|
|
2016
Q1 | $2.46M | Buy |
65,705
+51,640
| +367% | +$1.95M | ﹤0.01% | 2266 |
|
|
2015
Q4 | $607K | Sell |
14,065
-12,965
| -48% | -$548K | ﹤0.01% | 3655 |
|
|
2015
Q3 | $1.01M | Buy |
27,030
+7,505
| +38% | +$266K | ﹤0.01% | 3075 |
|
|
2015
Q2 | $664K | Buy |
19,525
+3,060
| +19% | +$104K | ﹤0.01% | 3454 |
|
|
2015
Q1 | $583K | Sell |
16,465
-13,800
| -46% | -$494K | ﹤0.01% | 3588 |
|
|
2014
Q4 | $1.03M | Buy |
30,265
+15,609
| +107% | +$554K | ﹤0.01% | 3105 |
|
|
2014
Q3 | $565K | Buy |
14,656
+5,611
| +62% | +$209K | ﹤0.01% | 3445 |
|
|
2014
Q2 | $352K | Sell |
9,045
-322
| -3% | -$12K | ﹤0.01% | 3693 |
|
|
2014
Q1 | $320K | Buy |
9,367
+1,435
| +18% | +$44.5K | ﹤0.01% | 3898 |
|
|
2013
Q4 | $167K | Sell |
7,932
-10,050
| -56% | -$254K | ﹤0.01% | 4812 |
|
|
2013
Q3 | $422K | Buy |
17,982
+16,061
| +836% | +$456K | ﹤0.01% | 3569 |
|
|
2013
Q2 | $52K | Buy |
+1,921
| New | +$55.7K | ﹤0.01% | 5363 |
|
Other funds holding MYGN
VPC
Citigroup's MYGN Position: Q2 2026 in Review
Citigroup increased its Myriad Genetics (MYGN) stake by 587% in Q2 2026, buying an estimated $453K and bringing the position to 116,820 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #3742.
Citigroup first reported a position in MYGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.58M in Q4 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Citigroup held 116,820 shares of Myriad Genetics worth $667K as of Q2 2026.
- Citigroup bought 99,813 Myriad Genetics shares in Q2 2026, an estimated $453K.
- Myriad Genetics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3742 holding.
- Citigroup first reported a position in Myriad Genetics in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Myriad Genetics position peaked at $6.58M in Q4 2018.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.